News

Chewy, Inc. Launches Offering of Class A Common Stock

Chewy, Inc. Launches Offering of Class A Common Stock

Chewy, Inc. Launches Class A Common Stock Offering

Chewy, Inc. (NYSE: CHWY), a popular hub for pet owners and their companions, has just announced a notable underwritten stock offering. This initiative involves $500 million worth of its Class A common stock and is being led by Buddy Chester Sub LLC, which is associated with BC Partners Advisors LP, Chewy's largest investor.

Offering Details

The Selling Stockholder will provide the underwriters with a 30-day option to acquire an additional $75 million in Class A common stock. It's worth mentioning that Chewy will not be selling any shares or receiving any funds from this offering. The completion of this offering depends on market conditions and other factors, meaning the timeline is a bit unpredictable.

Simultaneous Share Buyback

In a significant simultaneous action, Chewy has committed to purchasing $300 million of its Class A common stock from the Selling Stockholder. This repurchase will be based on the price determined by the underwriters in the public offering cited earlier. A special committee, composed entirely of independent directors who are not affiliated with BC Partners, has approved this buyback.

Once completed, the shares acquired through this buyback will be canceled, emphasizing Chewy’s focus on effective equity management. This transaction is part of a larger context, as it coincides with Chewy's existing $500 million share repurchase program that was approved previously. Importantly, the outcome of the Offering is not reliant on the successful completion of the Concurrent Repurchase, although the latter does depend on the former.

Involvement of the Underwriting Team

Morgan Stanley is serving as the lead book-running manager for this offering. Chewy has already submitted a registration statement, which includes a detailed prospectus, to the Securities and Exchange Commission (SEC) to facilitate the process. Interested investors are encouraged to check out the prospectus and other documents available on the SEC's EDGAR database for more information about Chewy and this offering.

How to Access the Prospectus

For anyone interested in delving deeper into this offering, Chewy and its underwriters will work together to ensure the distribution of the prospectus supplement and other related documents. Investors can contact Morgan Stanley & Co. LLC through their Prospectus Department to obtain direct information regarding the offering and gather comprehensive insights.

About Chewy, Inc.

Chewy’s mission is to be the most trusted and convenient option for pet parents. The company takes pride in being a leading online retailer of pet products, boasting a wide variety of high-quality items and services at competitive prices, all while delivering outstanding customer care. Chewy continually innovates ways for customers to engage with their brand, offering mobile apps and websites that help pet owners tailor to their pets' needs effectively.

Partnering with around 3,500 reputable brands in the pet industry, Chewy provides an extensive selection of approximately 115,000 products and services. This vast array fosters a strong, customer-focused experience that supports pet care journeys for its customers.

Frequently Asked Questions

Why is Chewy, Inc. conducting a public offering?

This public offering aims to raise funds for the Selling Stockholder, and it won't directly benefit Chewy since they're not selling any shares.

Who is overseeing the public offering?

Morgan Stanley is the lead book-running manager for the offering, ensuring its smooth and effective execution.

What happens to the shares that Chewy repurchases?

After the shares are repurchased, they'll be canceled and retired, which reduces the overall number of outstanding shares.

How can I get more details about the offering?

Yes, those interested can find detailed documents on the SEC's website or directly contact Morgan Stanley.

What is the impact of this offering on Chewy's existing share buyback program?

This offering and the concurrent buyback are separate from the previously authorized share repurchase program, which remains unchanged.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Andavi Acquires Infilect: Shaping Future of Retail AI

Updated Category News Views 104

Big Moves in Retail AI: Andavi Snaps Up Infilect Here we go, folks! Andavi Solutions just dropped a doozy on the market. They've bagged Infilect, an AI technology headliner based in Bengaluru, and it's got some tongues wagging. The New York-headquartered outfit, known for its slick sales execution tech in the beverage and consumer goods sectors, is betting big on AI. And...

Continue Reading
Eunice Goldstein Winery's Luxe Holiday Gifting Revolution

Updated Category News Views 138

Shaking Up the Holiday Gifting Game You ever feel like holiday gifting is stuck in a rut? Same old generic bottles and baskets. But, here comes Eunice Chiweshe Goldstein Winery, charging in with a fresh take on holiday generosity. This ain't just about selling wine—this is about crafting an experience for both giver and receiver. Perfect for those looking to ditch the...

Continue Reading
Smartphone Durability: What Investors Need to Know

Updated Category News Views 109

When a Drop Becomes a Cost-Benefit Analysis As someone who’s been around the block more times than I care to count, here’s a nugget for you: we rarely think about all the little things that could drill a hole in our pockets until they do. Take smartphones, the ubiquitous little beasts we carry everywhere. An accidental drop, one moment you’re butterfingering it in...

Continue Reading
AVENIR GLOBAL Snaps Up Marker Collective: Bold Move

Updated Category News Views 12

AVENIR GLOBAL Expands Its Empire In what looks like a bold stride forward, AVENIR GLOBAL's acquisition of Marker Collective ain't just some casual Sunday stroll. This is a hefty leap into the big league of communications, catapulting the Montreal-based outfit into the ranks of the world's top 15 firms by revenue. Might say it's one hell of a way to celebrate the company's...

Continue Reading
Freedom Bank Taps McIntyre as CRE Powerhouse Leader

Updated Category News Views 77

Dan McIntyre's latest move to Freedom Bank of Virginia as Senior Vice President screams strategy. This isn’t just another shuffle of executive chairs—it’s a calculated play to deepen their roots in the fiercely competitive Washington D.C. real estate market. Now, why should investors like you sit up and take notice? Well, when a bank with hefty capital and a yawning...

Continue Reading
AAN Seeks Donations to Drive Crucial Brain Research

Updated Category News Views 58

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

Continue Reading
Nutramax Boosts Young Scientists with Lindau Sponsorship

Updated Category News Views 68

Nurturing the Next Generation with Nobel Insights If you think science is just numbers and facts, you'd better wrap your head around what Nutramax Laboratories is pulling off. The company sent five bright-eyed young scientists to the 75th Lindau Nobel Laureate Meeting in Germany, where minds sharper than a new scalpel gather to shape the frontiers of research. This isn't...

Continue Reading
Pavlus Travel's Bucket-List Trips in High Demand for 2027

Updated Category News Views 16

Luxury Travel is Having a Moment A fancy vacation isn't just a postcard on the wall anymore—it's now, more than ever, a box folks are itching to check off their lists. Call it a midlife shift or just the world shrugging off its pandemic blues, but high-end travelers are saying, "The time is now," and they're serious. Pavlus Travel, a top name in the lux travel space,...

Continue Reading
Fingercheck Teams with Meridio to Secure Employee Health

Updated Category News Views 148

New Opportunities for Small Business Employees Man, oh man, the little guy finally gets a seat at the table, thanks to Fingercheck. This latest scoop? They've partnered with Meridio, so now small and mid-sized businesses can offer medical, dental, and vision coverage just like the big shots. It's about time, right? These folks have been left out in the cold far too long...

Continue Reading
AMTD IDEA Eyes Third NYC Hotel Amid Uncertain Deals

Updated Category News Views 50

AMTD IDEA's Expansive NYC Hotel Pursuits When it comes to real estate, AMTD IDEA seems to be on a buying spree in the Big Apple. The company is now eyeballing a third hotel in New York City, marking what could be yet another bold move in its strategic expansion. But let's be frank: deals like these come with their fair share of volatility. As it stands, they're in...

Continue Reading

Top 5 Most Recently Viewed Articles

NeurAxis Sees Revenue Surge and Expanded FDA Approvals

Updated Category News Views 165

NeurAxis Publishes Impressive Financial Results NeurAxis, Inc. (NYSE: NRXS), a pioneering medical technology company focused on developing neuromodulation therapies, has announced remarkable financial results for the third quarter of 2025. The announcement highlights a significant 22% growth in revenues compared to the same period last year, cementing NeurAxis's position...

Continue Reading
Exploring the Future of HealthTech: Market Growth Insights

Updated Category News Views 135

HealthTech Market Overview The healthtech market is experiencing monumental growth fueled by a surge in health consciousness and the increasing demand for preventive care. A significant factor contributing to this expansion is the aging population, coupled with strong governmental initiatives and supportive policies that are shaping market trends. Current Market Valuation...

Continue Reading
FRM's Barrier Restore Cream to Debut at Walmart

Updated Category News Views 15

New Product, New Outlet Roll over, skincare market! There's a fresh player stepping into the retail arena, and it's got some newcomers excited. FRM by Jasmanique is prepped to introduce its “FRM 01: Barrier Restore Cream” at none other than Walmart this fall. Now, you might wonder how this duo is going to shake things up, especially for those of us glued to the ticker...

Continue Reading
Hongli Group Inc. Faces Nasdaq Bid Price Compliance Challenge

Updated Category News Views 142

Hongli Group Inc. Faces Nasdaq Bid Price Compliance Challenge In a recent development, Hongli Group Inc. (Nasdaq: HLP) received a deficiency letter from the Nasdaq Listing Qualifications Department, indicating a non-compliance issue with the minimum bid price required for continued listing. This notice was issued based on the closing bid price of the company's ordinary...

Continue Reading
Kenneth Leech: Facing Fraud Charges for Client Mismanagement

Updated Category News Views 354

Overview of Kenneth Leech's Fraud Charges Kenneth Leech, a veteran in the finance industry and former co-chief investment officer at Western Asset Management Co., now faces alarming legal challenges. Recently charged with running a fraudulent scheme exceeding $600 million, Leech is accused of unethical trading practices where he prioritized certain clients over others....

Continue Reading